ARCHIVES

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

This article is from The Cancer Letter archive.

Vol. 31 No. 07 | February 18, 2005

Download PDF Visit The Full Archive

Related Articles

Organ Systems Program Reorganization Complete; Annual Conferences To Replace Working Groups

May 26, 1989

De-Emphasis of Tradition Grants Still Haunts Some; “Recent NCI Actions Held Up As Evidence

May 21, 1976

Cancer Control Reps Discuss Issues of ‘80s

October 17, 1980

HCFA Abadons Plan To Cut Cancer Drug Payments.

September 15, 2000

President’s Budget Takes Care If R01s, P01s, Fattens Up NTP, Devastates Construction Grants

February 1, 1980

NCAB Calls For Modification Of Rules For NIH Scientist-Industry Collaboration

December 10, 2010